Biomarkers

Hormonal therapies are prescription treatments that involve hormones, hormone-related signaling pathways, or medications that affect endocrine function.

Yes. Comprehensive labs are mandatory before any hormonal therapy is prescribed. Prescribing without lab data is unsafe and clinically irresponsible, regardless of how obvious the symptoms may seem.

Compounded preparations are not FDA-approved. The FDA does not evaluate compounded products for safety, effectiveness, or quality. We work exclusively with licensed 503A compounding pharmacies that operate under federal and state regulatory oversight.

Yes. HCG has standalone clinical applications for men with hypogonadal symptoms, even when testosterone levels are within normal reference ranges. Your provider will determine whether HCG monotherapy, combination with TRT, or a different approach is most appropriate based on your labs and clinical picture.

Levothyroxine provides T4 only, which the body must convert to active T3. Some patients don't convert efficiently, and their symptoms persist despite technically adequate T4 levels. Compounded combination therapy provides both hormones directly, and published evidence supports improved outcomes for symptomatic patients who haven't responded to T4 alone.

Nandrolone is an anabolic-androgenic compound, yes. At therapeutic doses prescribed by a licensed provider with ongoing lab monitoring, it serves as a medical intervention for specific musculoskeletal and connective tissue conditions. It is prescribed based on clinical need, monitored closely, and adjusted based on lab work, the same standard applied to every therapy we offer.

Testosterone therapy focuses specifically on testosterone replacement or testosterone optimization. Hormonal therapies is a broader category that may include medications affecting testicular signaling, thyroid hormone levels, growth hormone-related pathways, or other hormone-responsive systems.